Alvotech S.A. (ALVO): Sotuvning operatsion marjasi

Alvotech Biopharmaceuticals - ALVO emitenti grafik logotipi

Alvotech kompaniyasining uzoq hayot sikliga ega biosimilar dori vositalariga tikkan garovi, foizlar va soliqlar to'lanishidan oldingi operatsion foyda darajasi bilan ko'rsatilganidek, barqaror daromadni ta'minlaydi. 11.50 qiymati ushbu baholash parametrini xarakterlaydi. Alvotech global sherikliklar orqali original dori vositalarining hamyonbop analoglari ekotizimini ishlab chiqmoqda. Maxsus harorat nazorat qilinadigan havo yuk tashuvlarining optimallashtirilgan tarmog'i ta'minot ishonchliligini kafolatlaydi.

ALVO: alvotech.com Sotuvning operatsion rentabelligi 28.04.2023 - 19.11.2026

Alvotech - tahliliy kesimlar va asosiy koʻrsatkichlar (ALVO)

- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning asosiy tahlili:ALVO, Alvotech Corp
Alvotech Biopharmaceuticals tayyor mahsulotlari

Yuqori operatsion marja biznesning fundamental barqarorligini tasdiqlaydi va soliqlar hamda foiz majburiyatlarigacha bo'lgan asosiy operatsiyalardan foyda olish qobiliyatini namoyish etadi. Operatsion marja kuzatuvchisini tahlil qilish orqali investor FDA ning qat'iy tartibga soluvchi nazorati va biosimilarlarni AQSh hamda Yevropa Ittifoqi bozorlariga chiqarishda patent to'siqlarini yengib o'tish bilan bog'liq ulkan xarajatlar fonida Alvotech (ALVO) kompaniyasining xarajatlarni boshqarish samaradorligini baholaydi.

Muhim raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Operatsion faoliyat rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.